Company intelligence / Profile preview
PIK-PHARMA
Moscow, Russia
- Ownership
- Private
- Employees
- ~500
- Development stage
- Other
01
Overview
PIK-PHARMA is a prominent Russian pharmaceutical company founded in 1994, focusing on the full-cycle development and production of medicines. It is particularly recognized for its innovative portfolio in the fields of neurology, metabolic disorders, and pediatrics, featuring flagship products like the nootropic Pantogam and the metabolic agent Elkar. The company operates specialized manufacturing sites, including PIK-PHARMA Khim for active pharmaceutical ingredient (API) synthesis and PIK-PHARMA Leki for finished dosage forms. By integrating R&D with modern GMP-compliant production, PIK-PHARMA maintains a strong market presence in Russia and the CIS region.
- Therapeutic areas
- EndocrinologyNeurologyCardiovascularMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Russian Academy of SciencesMoscow State University
Beyond the preview
Go deeper on PIK-PHARMA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PIK-PHARMA.